Stress effect on myocardialperfusion sca

Not Applicable

• Conditions: Condition 1: Ischemic Heart Disease. Condition 2: Ischemic Heart Disease. Condition 3: Ischemic Heart Disease.; Angina pectoris; Other acute ischaemic heart diseases; Chronic ischaemic heart disease

• Registration Number: IRCT201205279881N1
• Lead Sponsor: Deputy of Research, Tehran University of Medical Sciences

Brief Summary

Not available

Detailed Description

Not available

Study Timeline

• Results First Posted: 1900-01-01
• Last Update Posted: 22 February 2018

Recruitment & Eligibility

• Status: Complete
• Sex: All
• Target Recruitment: 98

Inclusion Criteria

age more than 20 years; non-pregnant; non-breast feeding (for female patients); intermediate pretest probability of coronary artery disease on the basis of Framingham Risk Score and Exclusion criteria: Asthma; chronic renal failure; left bundle branch block; severe AV block; Irregularly cardiac arrythmia; pacemaker; disability to perfom submaximal exercise; congestive heart failure with EF<15%; hepatic insufficiency; cholestasis; severe aortic stenosis; patient refusal to cooperate.

Exclusion Criteria

Not provided

Study & Design

• Study Type: interventional
• Study Design: Not specified

Primary Outcome Measures

Name	Time	Method
Myocardial to liver activity ratio. Timepoint: 15, 60, 120 and 180 minutes after radiotracer injection. Method of measurement: Reconstruction software of SPECT.;Myocardial to colon (splenic curve) activity ratio. Timepoint: 15, 60, 120 and 180 minutes after radiotracer injection. Method of measurement: Reconstruction software of SPECT.